Non Animal Testing Database
EnglischDeutsch

Nanoparticles to detect and inhibit β-amyloid aggregation

2018
Universidad de Chile, Independencia, Chile(1)
Universidad Tecnológica Metropolitana, San Joaquín, Chile(2)
A microfluidic system is used to generate magneto-plasmonic nanoparticles coupled with peptide D1, which selectively binds to β-amyloid peptides associated with Alzheimer's disease. Afterwards, these nanoparticles were treated to reduce cytotoxicity, as demonstrated by the high cell viability in cytotoxic assays performed on a human neuroblastoma cell line. Overall, these nanoparticles inhibit fibril formation and aggregation, thus they could be potential therapeutic and diagnostic tools for Alzheimer's disease.
Peptide functionalized magneto-plasmonic nanoparticles obtained by microfluidics for inhibition of β-amyloid aggregation
M J Kogan(1), N Hassan(2)
#787
Added on: 08-04-2021
Back to Top
English German

Warning: Internet Explorer

The IE from MS no longer understands current scripting languages, the latest main version (version 11) is from 2013 and has not been further developed since 2015.

Our recommendation: Use only the latest versions of modern browsers, for example Google Chrome, Mozilla Firefox or Microsofrt Edge, because only this guarantees you sufficient protection against infections and the correct display of websites!